Medley Management Inc. MDLY
5.88
0.00
0.00%
as of 12 Jun
- Market cap
- —
- P/E
- 0.0×
Follow MDLY
| Dec '20 | Sep '20 | Jun '20 | Mar '20 | Older periods | |
|---|---|---|---|---|---|
| 2.18% | 4.07% | 4.43% | 4.04% |
+8 more TTM periods Free account |
|
| (6.49%) | (8.67%) | (9.26%) | (7.50%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
11.82% | 23.52% | 27.68% | 32.67% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(5.10) | (1.66) | 3.70 | 2.39 | |
Free Cash Flow |
(3.28) | (1.06) | 2.34 | 1.49 | |
Capital Expenditures |
(0.10) | (0.11) | (0.13) | — | |
Piotroski F-Score |
1.00 | 2.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
483.56% | (31.26%) | 48.84% | 13.00% | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.86 | 1.01 | 1.18 | 1.32 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
458.47 | 412.27 | 363.89 | 282.94 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.10) | 0.14 | 0.14 | 0.22 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
49.43% | 45.46% | 46.35% | 43.94% | |
Share Based Compensation of Revenue |
12.48% | 13.95% | 14.85% | 16.05% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.16 | 0.19 | (0.46) | (0.32) | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(0.04) | (0.02) | (0.02) | 0.00 | |
Revenue per Share |
51.68 | 55.43 | 61.14 | 68.88 | |
Operating CF per Share |
(4.94) | (1.48) | 3.91 | 2.39 | |
Capex per Share |
(0.16) | (0.18) | (0.21) | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(8.24%) | (13.96%) | (13.82%) | (10.97%) |
Columns are period end dates